SCHEMBL24324843

SCHEMBL24324843

COC(=O)c1cc(F)c(O)cc1N

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 7/20 0.58
ALDH1A1 P00352 5/20 0.56
GAA P10253 6/20 0.51
HSD17B10 Q99714 3/20 0.51
MAPT P10636 2/20 0.51
HPGD P15428 2/20 0.51
GLA P06280 2/20 0.51
CASP1 P29466 1/20 0.51
CASP7 P55210 1/20 0.51
ATM Q13315 1/20 0.51
CFTR P13569 6/20 0.51
ABL1 P00519 1/20 0.50
TSHR P16473 2/20 0.49
ALOX15 P16050 1/20 0.49
CA12 O43570 2/20 0.46
CA1 P00915 2/20 0.46
CA2 P00918 2/20 0.46
CA7 P43166 2/20 0.46
CA9 Q16790 2/20 0.46
CA14 Q9ULX7 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29611549 1.00 KDM4E (0.58) KDM4EALDH1A1GAAHSD17B10MAPT
SCHEMBL12303359 0.95 KDM4E (0.56) KDM4EALDH1A1GAAHSD17B10MAPT
SCHEMBL195591 0.89 KDM4E (0.61) KDM4EALDH1A1GAAHSD17B10MAPT
SCHEMBL2900514 0.87 KDM4E (0.59) KDM4EALDH1A1GAAHSD17B10MAPT
SCHEMBL25342477 0.86 CA12 (0.50) KDM4EALDH1A1GAAHSD17B10MAPT
SCHEMBL31024702 0.86 CA12 (0.50) KDM4EALDH1A1GAAHSD17B10MAPT
SCHEMBL23906095 0.85 CA12 (0.48) KDM4EALDH1A1GAAHSD17B10MAPT
SCHEMBL3616519 0.84 KDM4E (0.56) KDM4EALDH1A1GAAHSD17B10MAPT
SCHEMBL28149249 0.84 KDM4E (0.56) KDM4EALDH1A1GAAHSD17B10MAPT
SCHEMBL16858435 0.82 KDM4E (0.54) KDM4EALDH1A1GAAHSD17B10MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230357253-A1 AGONISTS OF STIMULATOR OF INTERFERON GENES STING THE SCRIPPS RESEARCH INSTITUTE 2023-11-09 US disclosed
US-20230357253-A1 AGONISTS OF STIMULATOR OF INTERFERON GENES STING THE SCRIPPS RESEARCH INSTITUTE 2023-11-09 US disclosed
US-20230357253-A1 AGONISTS OF STIMULATOR OF INTERFERON GENES STING THE SCRIPPS RESEARCH INSTITUTE 2023-11-09 US disclosed
CN-116940567-A Agonists of the interferon gene stimulator STING 斯克里普斯研究学院 2023-10-24 CN disclosed
EP-4208260-A1 AGONISTS OF STIMULATOR OF INTERFERON GENES STING The Scripps Research Institute (US) 2023-07-12 EP disclosed
WO-2022051765-A1 AGONISTS OF STIMULATOR OF INTERFERON GENES STING THE SCRIPPS RESEARCH INSTITUTE (US) 2022-03-10 WO disclosed
WO-2022051765-A1 AGONISTS OF STIMULATOR OF INTERFERON GENES STING THE SCRIPPS RESEARCH INSTITUTE (US) 2022-03-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230357253-A1 AGONISTS OF STIMULATOR OF INTERFERON GENES STING STING1, IRF3, CGAS KDM4E 4074/4885ALDH1A1 4453/4885GAA 602/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.